Troventolum

Chemical name

Yodmetilat tropinovogo ester d,l-(2-гидроксиметил-2-фе нил)масляной acid

Gross

C19-H30-I-N-O2

Characteristics

White or white with a yellowish sheen crystalline powder. It is soluble in water.

Of drugs

The drugs-bronhodilatirtee, holinoliticescoe. And m-holinoblokiruta activity. Does predominantly m-holinoretseptora bronchus (a stronger and more lasting), as compared with other organs (heart, stomach, etc.). Bronhodilatiruty effect develops through 15-30 minutes after inhalation and maintained for a period of 4-5 hours It passes through GEB.

Indications

Bronhospasticski syndrome (treatment and prevention), with obstruguom chronic bronchitis, bronchial asthma (mild), acute and chronic pneumonia; Respiratory diseases, including in patients older.

Pregnancy and lactation

Contraindicated in pregnancy.

Contraindications

Glaucoma, pregnancy.

Side-Effects

Brown mouth, pershenie throat, ccomodation violation.

Specific guidance

There is evidence of possible use for the diagnosis of latent bronhospasticski syndrome.

Patient interaction

Compatible with other bronhorasshiratmi Programme (adrenomimetiki, derivatives xantina) and glukokortikoidami.

Precautions

If you have side effects may reduce the dose or an increase in the interval between ingalyatsiami. In more severe cases, a temporary cease treatment.

Dosing and Administration

Inhalation. Using 1-2 times (2 hits) every four to six hours, the initial dose of 40 micrograms. If necessary, increase the dose to 80 micrograms. Daily dose-equivalent 120-480.

Directory → Wegetotropona funds → Holinoliticaskie funds → M-holinolitiki → Troventolum